Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok). LSALT Peptide is developed for targeting organ inflammation often experienced in hospitalized COVID-19 patients. It focuses on therapeutic development of LSALT Peptide and other DPEP-1 targeting drug candidates for new indications where inflammation of the lungs, liver and kidneys is an unmet problem. It has additional technology platforms in its portfolio including AB569, which focuses on preventing antibiotic resistant bacterial infections; Borg, which is a peptide-solid surface interface, and MetaMx, which is a synthetic molecule that target brain tumor initiating cells and invasive glioma cells.


TSXV:ARCH - Post by User

Comment by SrPlataon Nov 25, 2021 5:41pm
97 Views
Post# 34166717

RE:New High

RE:New HighYes you are right, trading pattern was different today. Just remember tommorow US markets close 3 hourrs  early 1:00 EST. BTW there will be no Black Friday discounts on ARCH stock tomorrow. Thanks for the info on TSXV margin requirements, I am more familiar with the US margin requiremnts.

I agree stock is still super cheap, i bot more yesterday at $3.41 USD that is the highest price I have paid and it took a while for my limit order to get filled BTW lowest price I bot was .99 USD and avg $1.50 started buying in June 2021, after a friend asked me to chedk out ARCH. The more I researched and really dug into the company and the way they were financing their growth and stages of development the more I bought. When I really understood that management was on the side of the shareholders and were the largest holders of the stock the more I bought. When I really got my head around the potential market size the more I bought. When I realized they got as far as they have in a Phase 2 trial without the Wall Street sharks raising money for them with warrants attached, the more I bought. 

Happy Thanksgiving to all and especially my friend who asked me to check out ARCH



<< Previous
Bullboard Posts
Next >>